AI, Longevity, and the Health Revolution with Nayeema Raza

In this episode of the Newcomer podcast, Eric Newcomer and Nayeema Raza recap their inaugural AI Health and Longevity Summit, Deus Ex Medicina, highlighting key themes and discussions. They delve into the Trump administration's healthcare policies, the rivalry between AI companies like Abridge and Open Evidence, and the potential for pharmaceutical companies to invest in longevity treatments, drawing insights from interviews with industry leaders. The conversation also covers the role of wearable technology in health monitoring, debates around foundational models in healthcare AI, and the future of healthcare subscriptions and bundled services.

Outlines

Sign in to continue reading, translating and more.

Continue

Newcomer Pod

Introduction to AI, Healthcare Policy, and Longevity in Silicon Valley

AI Companies in Healthcare: Abridge vs. Open Evidence and Function Health's Data Use

GLP-1s, Preventative Care, and Samsung's Sleep Apnea Detection

The Role of AI in Personal Health Management and the Future of Healthcare Bundles

AI Arms Race in Healthcare and the Debate Over Foundational Models

AI, Longevity, and the Health Revolution with Nayeema Raza

Newcomer Pod

00:00Introduction to AI, Healthcare Policy, and Longevity in Silicon Valley

Introduction to AI, Healthcare Policy, and Longevity in Silicon Valley

07:01AI Companies in Healthcare: Abridge vs. Open Evidence and Function Health's Data Use

AI Companies in Healthcare: Abridge vs. Open Evidence and Function Health's Data Use

14:56GLP-1s, Preventative Care, and Samsung's Sleep Apnea Detection

GLP-1s, Preventative Care, and Samsung's Sleep Apnea Detection

21:51The Role of AI in Personal Health Management and the Future of Healthcare Bundles

The Role of AI in Personal Health Management and the Future of Healthcare Bundles

28:12AI Arms Race in Healthcare and the Debate Over Foundational Models

AI Arms Race in Healthcare and the Debate Over Foundational Models